Medical News Today
Saturday, November 12, 2016
J&J arthritis drug goes up against Humira, with mixed results
(Reuters) - Johnson & Johnson said its experimental sirukumab treatment for rheumatoid arthritis showed mixed results against AbbVie Inc's top-selling Humira in a large trial.
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment